How long will coronavirus vaccines protect people?


“A year ago I tried the Moderna vaccine to see if it was safe. (Spoiler: It is!) Now, on my #COVIDvaccine anniversary, I am happy to share that I just received a third dose. This booster experiment will reveal (1 ) if the vaccines tailored to the strains increase immunity and (2) if they are safe, “Haydon, a communications specialist at the University of Washington, said via Twitter last Saturday.

“It is not clear if this new modified version will be necessary,” Haydon told CNN in a telephone interview.

Doctors are concerned that the coronavirus could end up being like influenza, requiring a new vaccine every year, both because circulating strains mutate rapidly and because the vaccine’s immunity wears off quickly.

Although initial evidence suggests that immunity from coronavirus vaccination provides long-lasting protection, vaccine manufacturers have begun manufacturing and testing versions of their vaccines that protect against worrisome variants of the virus. That includes version B.1.351 that was first seen in South Africa, which carries a mutation that, in laboratory experiments, appears to allow it to slightly evade the human immune response.
The latest report from vaccine maker Pfizer shows that people in South Africa who received their coronavirus vaccine after B.1.351 became the dominant circulating virus were still very heavily protected from infection, something that supports laboratory experiments. who have shown that the vaccine causes such a strong infection. and a broad immune response that provides a cushion against the effects of mutant viruses.

“It’s still close enough that we have good protection,” said Scott Hensley, an immunologist and vaccine expert at the University of Pennsylvania.

Coronavirus Vaccine Launch in US Gets 'Less Complicated'

But vaccine manufacturers are taking no chances. The trial Haydon is participating in is testing not only a third dose of the Moderna vaccine adjusted to specifically protect against B.1.351, that’s what he got, but also a third dose of the original vaccine in some volunteers, to see if the The enhanced immune response is safe and offers an advantage.

A report published last month by Pfizer suggests that people who receive both doses maintain strong immunity for at least six months. Experts have gone to great lengths to point out that this does not mean that immunity stops after six months. It means that the longest trial volunteers have been followed to see what their immunity is. It’s likely to last much longer, Hensley said.

“I wouldn’t be surprised if we knew a year from now that these vaccines are still producing a strong immune response,” Hensley told CNN.

“I wouldn’t be surprised if this is a vaccine that we only get once.”

Covid-19 reinfections are rare, but more common in people 65 and older, study finds

That would make the vaccine look more like measles vaccines than flu vaccines. Measles vaccination protects against lifetime infection in 96% of people.

Protection from Pfizer’s two-dose vaccine remains above 91% even at six months, according to the company. It has released the details in a statement, not a formal scientific publication, and the data covers only a few thousand people. But if it holds up, it’s an indication that both the Pfizer and Moderna vaccines elicit a long-lasting immune response, experts say.

Hensley says that the technology used by both vaccines – the delivery of genetic material known as messenger RNA from mRNA – is especially powerful.

“The antibody responses elicited by these mRNA vaccines are incredibly high. What we know in animal models with other mRNA vaccines that have been tested before: We know that those antibody responses are incredibly long-lasting and do not decline over time.” “said Hensley, whose lab has been testing experimental mRNA vaccines for years.

Pfizer Vaccine Single Shot Provides Strong Protection for Those Who Have Had Covid-19, UK Studies Suggest

While coronavirus vaccines are, of course, new (the virus has only been around since late 2019), mRNA technology has been studied for many years and has been used to make vaccines against influenza, Ebola, and the virus. Zika.

Several studies have indicated this with the coronavirus vaccine.

In January, a team led by Dr. Alicia Widge of the National Institute of Allergy and Infectious Diseases wrote the New England Journal of Medicine to say that their research showed that two doses of Moderna’s vaccine produced many antibodies that decreased very slightly with the weather. The vaccine also caused the body to produce immune cells known as T cells and B cells that can keep defenses active for years. The vaccine-induced immune response was stronger and less variable than the immune response that follows a natural infection, they found.

Another study in the New England Journal of Medicine in February showed that blood drawn from people who received the Pfizer / BioNTech Covid-19 vaccine continued to produce an immune response against B.1.351.

Moderna and Pfizer test vaccine strategies against new variants

“Although we do not yet know exactly what level of neutralization is required for protection against Covid-19 disease or infection, our experience with other vaccines tells us that the Pfizer vaccine is likely to offer relatively good protection against this new variant.” Scott said. Weaver, director of the Human Immunity and Infections Institute at the University of Texas Medical Branch, told CNN at the time.

However, last month, South African virologists argued that there is mounting evidence that the vaccines being developed do not work as well against B.1.351 and urged vaccine manufacturers to start adjusting their formulas now.

Although he is participating in clinical trials that require regular blood draws to test his immunity, Haydon has no idea how well protected he is from the virus.

“I know that early in the trial, all of the participants and I developed neutralizing antibodies, the kind you are looking for. That was clear many, many months ago,” Haydon said. “But the level of those antibodies, and how the levels have changed over time, is not something they tell me. That is one of the main things that is being evaluated during the study.”

Lab Studies Suggest Pfizer and Moderna Vaccines May Protect Against Coronavirus Variant

He had a strong reaction to the first round of vaccination and said that the third dose he had just received caused some effects as well.

“Flulike is the correct way to describe my symptoms,” he said. “I ended up with a fever, chills, a little nausea, a headache,” he added.

Immunologists say it is a sign that the immune system is responding to the vaccine, although people who do not report symptoms also develop an immune response, so the symptoms do not seem to suggest that someone has a better response than someone who does not. fever.

Haydon doesn’t know if his answer this time says anything about the level of immunity he still had from the first dose he was given a year ago.

What you do know is that you cannot behave as if you are completely immune. So he still wears a mask every time he goes out and has avoided almost every trip.

“We live in a world where most people are not vaccinated. Just because you are vaccinated yourself doesn’t change everything for you,” Haydon said.

“We still have to take many of the same precautions as an unvaccinated person,” he added. Although the risk of going to the hospital is greatly reduced, the spread of the virus is a major concern. It’s not until recently that we started collecting data (showing) that vaccinated people also transmit the virus much less. So this is a recent discovery and a very good sign. “

.

Source link